Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Moleculin Biotech ( (MBRX) ) is now available.
Moleculin Biotech, Inc. has released a corporate presentation on their website, as indicated in a recent report, which is not to be filed under the Securities Exchange Act or the Securities Act unless specified. This announcement seems to focus on providing stakeholders with key information about the company’s operations and developments without affecting their legal obligations under these acts.
More about Moleculin Biotech
YTD Price Performance: -85.56%
Average Trading Volume: 49,444
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.94M
See more data about MBRX stock on TipRanks’ Stock Analysis page.
